Factors associated with compliance to thiazide diuretics among 8551 Chinese patients

Journal of Clinical Pharmacy and Therapeutics

Volumn 36, Issue 2, 2011, Pages 179-186

  Wong, M C S ^a   Jiang, J Y ^b   Griffiths, S M ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

anti hypertensive prescriptions; associated factors; Chinese; compliance; thiazide diuretics

Indexed keywords

THIAZIDE DIURETIC AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; ATTITUDE TO HEALTH; BLOOD PRESSURE REGULATION; CHINESE; COMORBIDITY; ETHNIC GROUP; FEMALE; HONG KONG; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT MONITORING; PRESCRIPTION; SOCIAL STATUS;

ADULT; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; COMORBIDITY; DATABASES, FACTUAL; FEMALE; HONG KONG; HUMANS; HYPERTENSION; MALE; MEDICATION ADHERENCE; RETROSPECTIVE STUDIES; SODIUM CHLORIDE SYMPORTER INHIBITORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 79952267119     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2010.01174.x     Document Type: Article

References (40)

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J, (2005) Global burden of hypertension: analysis of worldwide data. Lancet, 365, 217-223. (Pubitemid 40138015)
2. Ezzati M, Vander Hoorn S, Rodgers A, Lopez AD, Mathers CD, Murray CJ, Comparative Risk Assessment Collaborating Group (2003) Estimates of global and regional potential health gain from reducing multiple major risk factors. Lancet, 362, 271-280. (Pubitemid 36936837)
3. Fields LE, Burt VL, Cutler JA, Hughes J, Roccella EJ, Sorlie P, (2004) The burden of adult hypertension in the United States 1999 to 2000. A rising tide. Hypertension, 44, 398-404. (Pubitemid 39281486)
4. Singh RB, Suh IL, Singh VP, et al. (2000) Hypertension and stroke in Asia: prevalence, control and strategies in developing countries for prevention. Journal of Human Hypertension, 14, 749-763.
5. World Health Organization (2002) World Health Report 2002: reducing risks. Promoting healthy life. Geneva, Switzerland: World Health Organization. Available at:.
6. HDFP Cooperative Group (1979) Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality in persons with high blood pressure, including mild hypertension. JAMA, 242, 2562-2571.
7. SHEP Cooperative Research Group (1991) Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA, 265, 3255-3264.
8. Kaplan NM, Flynn JT, (2006) Kaplan's clinical hypertension, 9th edn. Philadelphia: Lippincott Williams & Wilkins, 264.
9. Whelton PK, He J, Muntner P, (2004) Prevalence, awareness, treatment and control of hypertension in North America, North Africa, and Asia. Journal of Human Hypertension, 18, 545-551. (Pubitemid 39173530)
10. Wolf-Maier K, Cooper RS, Kramer H, et al. (2004) Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension, 43, 10-17. (Pubitemid 38031904)
11. Flack JM, Novikov SV, Ferrario CM, (1996) Benefits of adherence to antihypertensive drug therapy. European Heart Journal, 17 (Suppl. A), 16-20. (Pubitemid 26129714)
12. Chobanian AV, Bakris GL, Black HR, et al. (2003) The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC-7 report. JAMA, 289, 2560-2572. (Pubitemid 37430158)
13. European Society of Hypertension-European Society of Cardiology Guidelines Committee (2003) European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. Journal of Hypertension, 21, 1011-1053.
14. World Health Organization (WHO)-International Society of Hypertension Guidelines Subcommittee (1999) World Health Organization (WHO)-International Society of Hypertension Guidelines for the Management of Hypertension. Journal of Hypertension, 17, 151-183.
15. Degli Esposti L, Degli Esposti E, Valpiani G, et al. (2002) A retrospective, population-based analysis of persistence with antihypertensive drug therapy in primary care practice in Italy. Clinical Therapeutics, 24, 1347-1357. discussion 1346. (Pubitemid 35026158)
16. Degli Esposti E, Sturani A, Di Martino M, et al. (2002) Long-term persistence with antihypertensive drugs in new patients. Journal of Human Hypertension, 16, 439-444. (Pubitemid 34685595)
17. Alderman MH, Madhavan S, Cohen H, (1996) Antihypertensive drug therapy: the effect of JNC criteria on prescribing patterns and patient status through the first year. American Journal of Hypertension, 9, 413-18.
18. Benson S, Vance-Bryan K, Raddatz J, (2000) Time to patient discontinuation of antihypertensive drugs in different classes. American Journal of Health System Pharmacy, 57, 51-54. (Pubitemid 30038915)
19. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J, (1997) The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. American Journal of Hypertension, 10, 697-704. (Pubitemid 27313814)
20. Wong MCS, Jiang Y, Griffiths S, (2009) Factors associated with antihypertensive drug compliance in 83,884 Chinese patients: a cohort study. Journal of Epidemiology and Community Health (in press).
21. Wong MCS, Jiang Y, Griffiths S, (2009) Factors associated with compliance, discontinuation and switching of calcium channel blockers in 20,156 Chinese patients. American Journal of Hypertension, 22, 904-910.
22. Wong MCS, Jiang Y, Griffiths S, (2009) Antihypertensive drug adherence among 6,408 Chinese patients on angiotensin converting enzyme inhibitors: a cohort study. Journal of Clinical Pharmacology doi:.
23. Wong MCS, Jiang Y, Griffiths S, (2009) Short-term adherence to β-blocker therapy among ethnic Chinese patients with hypertension: a cohort study. Clinical Therapeutics, 31, 2170-2177.
24. van Wijk BLG, Shrank WH, Klungel OH, Schneeweiss S, Brookhart MA, Avorn J, (2008) A cross-national study of the persistence of antihypertensive medication use in the elderly. Journal of Hypertension, 26, 145-153. (Pubitemid 350294860)
25. Lowry KP, Dudley TK, Oddone EZ, Bosworth HB, (2005) Intentional and unintentional nonadherence to antihypertensive medication. The Annals of Pharmacotherapy, 39, 1198-1203. (Pubitemid 40943169)
26. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J, (1996) Compliance with antihypertensive therapy among elderly Medicaid enrolees: the roles of age, gender, and race. American Journal of Public Health, 86, 1805-1808.
27. Cheung NT, (2007) Health informatics, Hospital authority, Hong Kong. Realizing the benefits of eHealth in Hong Kong. Available at: (accessed 19 September 2007).
28. Wong MCS, Jiang JY, Tang JL, Lam A, Fung H, Mercer SW, (2008) Health services research in the public healthcare system in Hong Kong: an analysis of over 1 million antihypertensive prescriptions between 2004-2007 as an example of the potential and pitfalls of using routinely collected electronic patient data. BMC Health Services Research, 8, 138.
29. Population by-census, 2006, Hong Kong Special Administrative Region, China. Available at: (accessed 9 October 2007).
30. Halpern MT, Khan ZM, Schmier JK, et al. (2006) Recommendations for evaluating compliance and persistence with hypertension therapy using retrospective data. Hypertension, 47, 1039-1048. (Pubitemid 44289157)
31. Lee JY, Kusek JW, Greene PG, et al. (1996) Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. American Journal of Hypertension, 9, 719-725. (Pubitemid 26271215)
32. Mallion JM, Baguet JP, Siche JP, Tremel F, de Gaudemaris R, (1998) Compliance, electronic monitoring and antihypertensive drugs. Journal of Hypertension, 16 (Suppl.), S75-S79. (Pubitemid 28085313)
33. Katz MH, (2006) Multivariable analysis: a practical guide for clinicians, 2nd edn. Cambridge: Cambridge University Press.
34. Chan L, Tsui PN, Ng YS, et al. (2007) Management of hypertension in general out patient clinics (GOPCs) of New Territories West Cluster: yesterday, today and tomorrow. Hong Kong Practitioner, 29, 470-480. Available at: (accessed 8 March 2009). (Pubitemid 351278451)
35. Carter BL, (2007) Adherence, quality of life, cost effectiveness, and the role of the pharmacist. In:, Lip GYH, Hall JE, eds. Comprehensive hypertension, chapter 92. Philadelphia: Mosby Elsevier, 1119-1127.
36. Vaur L, Vaisse B, Genes N, Elkik F, Legrand C, Poggi L, (1999) Use of electronic pill boxes to assess risk of poor treatment compliance: results of a large-scale trial. American Journal of Hypertension, 12, 374-380. (Pubitemid 29200055)
37. Kim MT, Han HR, Hill MN, Rose L, Roary M, (2003) Depression, substance use, adherence behaviours, and blood pressure in urban hypertensive Black men. Annals of Behavioral Medicine, 26, 24-31. (Pubitemid 36950987)
38. Caro JJ, Salas M, Speckman JL, Raggio G, Jackson JD, (1999) Persistence with treatment for hypertension in actual practice. Canadian Medical Association Journal, 160, 31-37. (Pubitemid 29054224)
39. Billups SJ, Malone DC, Carter BL, (2000) The relationship between drug therapy noncompliance and patient characteristics, health-related quality of life, and health care costs. Pharmacotherapy, 20, 941-949. (Pubitemid 30659791)
40. Knight EL, Bohn RL, Wang PS, Glynn RJ, Mogun H, Avorn J, (2001) Predictors of uncontrolled hypertension in ambulatory patients. Hypertension, 38, 809-814. (Pubitemid 34258675)